Literature DB >> 1591215

The role of T cells in the mediation of glomerular injury in Heymann's nephritis in the rat.

C G Quiza1, P L Leenaerts, B M Hall.   

Abstract

Heymann's nephritis (HN), a rat model of the membranous glomerulonephritis in man, is thought to be mediated by auto-Ig with subsequent activation of C. Whether T cell mechanisms are involved in the mediation of HN, apart from CD4+ cells providing help for auto-Ig production, was examined by treatment with mAb specific for T cell subsets for 6 weeks after immunization to induce HN. Anti-CD4 mAb therapy totally prevented proteinuria, in that at 6, 8, and 12 week treated rats had less than 15 mg/day of protein compared to controls that all had greater than 260 mg/day. Ig and C deposition in the glomerulus was significantly less and auto-Ig titers in serum were partially suppressed by anti-CD4 therapy. Anti-CD8 mAb therapy markedly reduced proteinuria at all time points, for example at 6 weeks there was 51 +/- 40 mg/day compared to 183 +/- 120 mg/day (P = 0.0003), but had no effect on auto-Ig titers or on Ig and C deposition in the glomerulus. A non-specific effect of high dose mouse mAb therapy was excluded by the findings that a mAb that did not bind to rat cells had no effect on the induction of HN and that serum C was not depleted in any of the mAb treated animals. A role for T effector mechanisms was further supported by the finding that therapy with mAb to T cell receptor alpha/beta chain or with cyclosporine also markedly delayed the onset of proteinuria. Examination of renal biopsies showed a T cell infiltrate in glomeruli and the interstitium of the untreated HN controls that was not present in MRC Ox35 or MRC Ox8 treated groups. This infiltrate included CD4+ and CD8+ T cells and macrophages. These results suggest induction of proteinuria in HN was totally dependent upon CD4+ T cells, and that CD4+ and CD8+ cells may have a direct role in the mediation of glomerular dysfunction in HN.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591215     DOI: 10.1093/intimm/4.4.423

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

2.  Heymann nephritis revisited--new insights into the pathogenesis of experimental membranous glomerulonephritis.

Authors:  E De Heer; J A Bruijn; P J Hoedemaeker
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 3.  Adhesion molecules in glomerulonephritis.

Authors:  D J Nikolic-Paterson; I W Main; H Y Lan; P A Hill; R C Atkins
Journal:  Springer Semin Immunopathol       Date:  1994

Review 4.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

5.  T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein.

Authors:  H Wu; G Y Zhang; J F Knight
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

6.  CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis.

Authors:  Yuan Min Wang; Geoff Yu Zhang; Min Hu; Tania Polhill; Andrew Sawyer; Jimmy Jianheng Zhou; Mitsuru Saito; Debbie Watson; Huiling Wu; Ya Wang; Xin Maggie Wang; Yiping Wang; David C H Harris; Stephen I Alexander
Journal:  J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 10.121

7.  Glomerular T cells in Heymann nephritis.

Authors:  G Walters; H Wu; J F Knight
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

8.  Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.

Authors:  D D Branisteanu; P Leenaerts; B van Damme; R Bouillon
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

9.  Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis.

Authors:  M J Penny; R A Boyd; B M Hall
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.